Epidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis

被引：6

作者：

Sajjadi-Jazi S.M. ^{[1
]}

Sharifi F. ^{[2
]}

Varmaghani M. ^{[3
,4
]}

Meybodi H.A. ^{[1
]}

Farzadfar F. ^{[4
]}

Larijani B. ^{[1
]}

机构：

[1] Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran

[2] Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran

[3] Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad

[4] Non-Communicable Disease Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran

来源：

Journal of Diabetes & Metabolic Disorders | 2018年 / 17卷 / 2期

关键词：

Epidemiology; Hyperthyroidism; Incidence; Iran; Prevalence;

D O I：

10.1007/s40200-018-0367-1

中图分类号：

学科分类号：

摘要：

Background: Hyperthyroidism is a systemic disorder that causes severe morbidity and is even fatal. Several studies have been performed in Iran to determine the epidemiologic properties of hyperthyroidism; however, they did not use a systematic approach or meta-analysis to evaluate the results. Therefore, this systematic review and meta-analysis aimed to evaluate the epidemiologic data on hyperthyroidism in Iran. Methods: In order to find all relevant papers published by October 2017, we searched both international (Web of Science, Scopus, PubMed, Embase, and Cochrane library) and Persian databases (Scientific Information Database, Magiran, and Barekat Knowledge Network System). Meta-analysis was performed using metaprop random effects analysis for prevalence and metaprop fix effect analysis for incidence by Stata statistical software. I 2 was used for the demonstration of heterogeneity. Results: Of 7667 published papers or conference proceeding, 7448 studies were removed after eliminating duplicates and reviewing titles/abstracts. Finally, after reviewing 219 full texts, 18 papers met the inclusion and exclusion criteria. The pooled prevalence of total, overt, and subclinical hyperthyroidism in general population were 2.43% (95% CI: 0.23–4.63%), 0.69% (95% CI: 0.21–1.18%), and 1.52% (95% CI: 0.14–2.89%), respectively. The pooled annual incidence of total hyperthyroidism was 2.2 (95% CI: 1.1–3.3) per 1000 population: 0.8 (0.1–1.4) and 1.3 (0.4–2.2) per 1000 population for overt and subclinical hyperthyroidism, respectively. Conclusions: This is the first systematic review and meta-analysis, which investigated the epidemiology of hyperthyroidism in Iran. It seems that the prevalence and incidence of hyperthyroidism among the general population in Iran is similar to that in other parts of the world. © 2018, Springer Nature Switzerland AG.

引用

页码：345 / 355

页数：10

共 50 条

[1]

De Leo S., Lee S.Y., Braverman L.E., Hyperthyroidism, Lancet (London, England), 388, 10047, pp. 906-918, (2016)

[2]

Cooper D.S., Hyperthyroidism, Lancet (London, England), 362, 9382, pp. 459-468, (2003)

[3]

Vanderpump M.P., Tunbridge W., The Epidemiology of Thyroid Diseases. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, pp. 398-406, (2005)

[4]

Aminorroaya A., Amini M., Hovsepian S., Prevalence of hyperthyroidism in Isfahan-Iran, in the year 2006, fifteen years after universal salt iodization: a community based study, Acta Endocrinol (Buc), 4, 3, pp. 273-285, (2008)

[5]

McLeod D.S., Cooper D.S., Ladenson P.W., Whiteman D.C., Jordan S.J., Race/ethnicity and the prevalence of thyrotoxicosis in young Americans, Thyroid, 25, 6, pp. 621-628, (2015)

[6]

Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., Et al., Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III), J Clin Endocrinol Metab, 87, 2, pp. 489-499, (2002)

[7]

Cooper D.S., Ridgway E.C., Thoughts on prevention of thyroid disease in the United States, Thyroid, 12, 10, pp. 925-929, (2002)

[8]

Garber J.R., Cobin R.H., Gharib H., Hennessey J.V., Klein I., Mechanick J.I., Et al., Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association, Thyroid, 22, 12, pp. 1200-1235, (2012)

[9]

Garmendia Madariaga A., Santos Palacios S., Guillen-Grima F., Galofre J.C., The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis, J Clin Endocrinol Metab, 99, 3, pp. 923-931, (2014)

[10]

Azizi F., Sheikholeslam R., Hedayati M., Mirmiran P., Malekafzali H., Kimiagar M., Et al., Sustainable control of iodine deficiency in Iran: beneficial results of the implementation of the mandatory law on salt iodization, J Endocrinol Investig, 25, 5, pp. 409-413, (2002)

← 1 2 3 4 5 →